SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005794-03-000039
Filing Date
2003-02-18
Accepted
2003-02-18 11:21:18
Documents
1
Period of Report
2003-02-14

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF BENEFICIAL OWNERSHIP f4jmg021403.txt 4 10335
  Complete submission text file 0001005794-03-000039.txt   12220
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Subject) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 03570343
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 340 EDGEMONT AVE SUITE 500 BRISTOL TN 37620 4239897211
GREGORY JOHN M (Reporting) CIK: 0001200376 (see all company filings)